{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:09:19Z","timestamp":1794028159675,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303824"],"award-info":[{"award-number":["82303824"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the 345 Talent Project of Shengjing Hospital of China Medical University"},{"name":"Basic Scientific Research Projects of Liaoning Provincial Education Department","award":["JYTQN2023023"],"award-info":[{"award-number":["JYTQN2023023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-01867-7","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T22:19:51Z","timestamp":1739398791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nomogram for predicting the risk of cervical lymph node metastases and recurrence in papillary thyroid carcinoma based on the thyroid differentiation score system and clinical characteristics"],"prefix":"10.1186","volume":"25","author":[{"given":"Yutong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"issue":"5","key":"1867_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MED.0000000000000359","volume":"24","author":"BR Roman","year":"2017","unstructured":"Roman BR, Morris LG, Davies L. The thyroid cancer epidemic, 2017 perspective. Curr Opin Endocrinol Diabetes Obes. 2017;24(5):332\u20136.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"1867_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/thy.2021.0662","volume":"32","author":"UC Megwalu","year":"2022","unstructured":"Megwalu UC, Moon PK. Thyroid Cancer Incidence and Mortality trends in the United States: 2000\u20132018. Thyroid. 2022;32(5):560\u201370.","journal-title":"Thyroid"},{"issue":"1","key":"1867_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12020-020-02207-6","volume":"68","author":"J Wang","year":"2020","unstructured":"Wang J, Yu F, Shang Y, Ping Z, Liu L. Thyroid cancer: incidence and mortality trends in China, 2005\u20132015. Endocrine. 2020;68(1):163\u201373.","journal-title":"Endocrine"},{"key":"1867_CR4","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3389\/fonc.2020.01586","volume":"10","author":"W Wang","year":"2020","unstructured":"Wang W, Zhang Z, Zhao Y, Xue W, Xia F, Li X. Management of lateral multiple-level metastasis in N1b papillary thyroid microcarcinoma. Front Oncol. 2020;10:1586.","journal-title":"Front Oncol"},{"issue":"10","key":"1867_CR5","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.3390\/cancers12103032","volume":"12","author":"SM Choi","year":"2020","unstructured":"Choi SM, Kim JK, Lee CR, Lee J, Jeong JJ, Nam KH, Chung WY, Kang SW. Completion total thyroidectomy is not necessary for papillary thyroid microcarcinoma with Occult Central Lymph Node Metastasis: a long-term serial Follow-Up. Cancers (Basel). 2020;12(10):3032.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1867_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/s12020-022-03173-x","volume":"78","author":"Z Luo","year":"2022","unstructured":"Luo Z, Hei H, Qin J, Zheng C, Gong W. Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes. Endocrine. 2022;78(3):484\u201390.","journal-title":"Endocrine"},{"issue":"3","key":"1867_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.asjsur.2015.03.015","volume":"39","author":"S Xue","year":"2016","unstructured":"Xue S, Wang P, Liu J, Li R, Zhang L, Chen G. Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: a retrospective study in China. Asian J Surg. 2016;39(3):131\u20136.","journal-title":"Asian J Surg"},{"issue":"5","key":"1867_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4103\/jcrt.JCRT_620_19","volume":"16","author":"H Huang","year":"2020","unstructured":"Huang H, Wu L, Liu W, Liu J, Liu Y, Xu Z. Long-term outcomes of patients with papillary thyroid cancer who did not undergo prophylactic central neck dissection. J Cancer Res Ther. 2020;16(5):1077\u201381.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"1867_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/00015458.2020.1828677","volume":"121","author":"H Atas","year":"2021","unstructured":"Atas H, Akkurt G, Saylam B, Tez M. Central neck dissection is an independent risk factor for incidental parathyroidectomy. Acta Chir Belg. 2021;121(1):36\u201341.","journal-title":"Acta Chir Belg"},{"issue":"8","key":"1867_CR10","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.12998\/wjcc.v8.i8.1350","volume":"8","author":"X Wu","year":"2020","unstructured":"Wu X, Li BL, Zheng CJ, He XD. Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma. World J Clin Cases. 2020;8(8):1350\u201360.","journal-title":"World J Clin Cases"},{"issue":"1","key":"1867_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hed.24852","volume":"40","author":"I Park","year":"2018","unstructured":"Park I, Her N, Choe JH, Kim JS, Kim JH. Management of chyle leakage after thyroidectomy, cervical lymph node dissection, in patients with thyroid cancer. Head Neck. 2018;40(1):7\u201315.","journal-title":"Head Neck"},{"issue":"8","key":"1867_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.biopha.2008.07.056","volume":"62","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Fallahi P, Ferrari SM, Carpi A, Berti P, Materazzi G, Minuto M, Guastalli M, Miccoli P. Dedifferentiated thyroid cancer: a therapeutic challenge. Biomed Pharmacother. 2008;62(8):559\u201363.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1867_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12022-021-09665-2","volume":"32","author":"M Volante","year":"2021","unstructured":"Volante M, Lam AK, Papotti M, Tallini G. Molecular Pathology of poorly differentiated and anaplastic thyroid Cancer: what do pathologists need to know? Endocr Pathol. 2021;32(1):63\u201376.","journal-title":"Endocr Pathol"},{"issue":"11","key":"1867_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrendo.2017.76","volume":"13","author":"E Molinaro","year":"2017","unstructured":"Molinaro E, Romei C, Biagini A, Sabini E, Agate L, Mazzeo S, Materazzi G, Sellari-Franceschini S, Ribechini A, Torregrossa L, et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol. 2017;13(11):644\u201360.","journal-title":"Nat Rev Endocrinol"},{"key":"1867_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.humpath.2018.07.027","volume":"82","author":"A Deeken-Draisey","year":"2018","unstructured":"Deeken-Draisey A, Yang GY, Gao J, Alexiev BA. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study. Hum Pathol. 2018;82:140\u20138.","journal-title":"Hum Pathol"},{"issue":"3","key":"1867_CR16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"CGAR Network","year":"2014","unstructured":"Network CGAR. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159(3):676\u201390.","journal-title":"Cell"},{"issue":"4","key":"1867_CR17","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1210\/clinem\/dgab851","volume":"107","author":"L Boucai","year":"2022","unstructured":"Boucai L, Seshan V, Williams M, Knauf JA, Saqcena M, Ghossein RA, Fagin JA. Characterization of subtypes of BRAF-Mutant papillary thyroid Cancer defined by their thyroid differentiation score. J Clin Endocrinol Metab. 2022;107(4):1030\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1867_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/ERC-17-0532","volume":"25","author":"KJ Na","year":"2018","unstructured":"Na KJ, Choi H. Immune landscape of papillary thyroid cancer and immunotherapeutic implications. Endocr Relat Cancer. 2018;25(5):523\u201331.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"1867_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12935-021-01939-3","volume":"21","author":"X Wang","year":"2021","unstructured":"Wang X, Peng W, Li C, Qin R, Zhong Z, Sun C. Identification of an immune-related signature indicating the dedifferentiation of thyroid cells. Cancer Cell Int. 2021;21(1):231.","journal-title":"Cancer Cell Int"},{"key":"1867_CR20","first-page":"dgae532","volume":"1","author":"JR Wang","year":"2024","unstructured":"Wang JR, Zafereo ME, Cabanillas ME, Wu CC, Xu L, Dai Y, Wang W, Lai SY, Henderson Y, Erasmus L, et al. The association between thyroid differentiation score and survival outcomes in papillary thyroid carcinoma. J Clin Endocrinol Metab. Aug 2024;1:dgae532.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1867_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.21037\/gs-21-906","volume":"11","author":"X Zhong","year":"2022","unstructured":"Zhong X, Lu Y, Yin X, Wang Q, Wang F, He Z. Prophylactic central lymph node dissection performed selectively with cN0 papillary thyroid carcinoma according to a risk-scoring model. Gland Surg. 2022;11(2):378\u201388.","journal-title":"Gland Surg"},{"key":"1867_CR22","doi-asserted-by":"publisher","first-page":"789310","DOI":"10.3389\/fendo.2021.789310","volume":"12","author":"X Gao","year":"2021","unstructured":"Gao X, Luo W, He L, Cheng J, Yang L. Predictors and a prediction model for Central Cervical Lymph Node Metastasis in Papillary thyroid carcinoma (cN0). Front Endocrinol (Lausanne). 2021;12:789310.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1867_CR23","doi-asserted-by":"publisher","first-page":"716728","DOI":"10.3389\/fendo.2021.716728","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Deng C, Shu X, Yu P, Wang H, Su X, Tan J. Risk factors and a prediction model of lateral lymph node metastasis in CN0 papillary thyroid carcinoma patients with 1\u20132 Central Lymph Node metastases. Front Endocrinol (Lausanne). 2021;12:716728.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1867_CR24","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u2013180.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1867_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41598-019-55991-1","volume":"10","author":"LH Jiang","year":"2020","unstructured":"Jiang LH, Yin KX, Wen QL, Chen C, Ge MH, Tan Z. Predictive risk-scoring Model for Central Lymph Node Metastasis and predictors of recurrence in papillary thyroid carcinoma. Sci Rep. 2020;10(1):710.","journal-title":"Sci Rep"},{"issue":"11","key":"1867_CR26","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ultrasmedbio.2018.06.020","volume":"44","author":"J Chen","year":"2018","unstructured":"Chen J, Li XL, Zhao CK, Wang D, Wang Q, Li MX, Wei Q, Ji G, Xu HX. Conventional ultrasound, Immunohistochemical Factors and BRAF(V600E) mutation in Predicting Central Cervical Lymph Node Metastasis of Papillary thyroid carcinoma. Ultrasound Med Biol. 2018;44(11):2296\u2013306.","journal-title":"Ultrasound Med Biol"},{"key":"1867_CR27","doi-asserted-by":"publisher","first-page":"807431","DOI":"10.3389\/fendo.2022.807431","volume":"13","author":"C Yan","year":"2022","unstructured":"Yan C, He X, Chen Z, Wang Y. Central Compartment Lymph Nodes have distinct metastatic patterns in different age groups. Front Endocrinol (Lausanne). 2022;13:807431.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1867_CR28","doi-asserted-by":"publisher","first-page":"822423","DOI":"10.3389\/fendo.2022.822423","volume":"13","author":"X Zha","year":"2022","unstructured":"Zha X, Miao Z, Huang X, Wang X, Xie R, Jin J, Zou D, Yang P, Huang Y. The risk stratification of papillary thyroid Cancer with Bethesda Category III (Atypia of undetermined Significance\/Follicular lesion of undetermined significance) by thyroid fine-needle aspiration could be assisted by Tumor size for Precision Treatment. Front Endocrinol (Lausanne). 2022;13:822423.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1867_CR29","doi-asserted-by":"publisher","first-page":"e929408","DOI":"10.12659\/MSM.929408","volume":"27","author":"M Lin","year":"2021","unstructured":"Lin M, Su Y, Wei W, Gong Y, Huang Y, Zeng J, Li L, Shi H, Chen S. Extra-thyroid extension prediction by Ultrasound quantitative method based on thyroid Capsule Response evaluation. Med Sci Monit. 2021;27:e929408.","journal-title":"Med Sci Monit"},{"issue":"3","key":"1867_CR30","first-page":"1020","volume":"102","author":"L Lamartina","year":"2017","unstructured":"Lamartina L, Borget I, Mirghani H, Al Ghuzlan A, Berdelou A, Bidault F, Deandreis D, Baudin E, Travagli JP, Schlumberger M, et al. Surgery for Neck recurrence of differentiated thyroid Cancer: outcomes and risk factors. J Clin Endocrinol Metab. 2017;102(3):1020\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1867_CR31","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.2967\/jnumed.121.261898","volume":"62","author":"R Seifert","year":"2021","unstructured":"Seifert R, Schafers MA, Heitplatz B, Kerschke L, Riemann B, Noto B. Minimal extrathyroid extension in papillary micro carcinoma of the thyroid is an independent risk factor for relapse through lymph node and distant metastases. J Nucl Med. 2021;62(12):1702\u20139.","journal-title":"J Nucl Med"},{"issue":"1","key":"1867_CR32","doi-asserted-by":"publisher","first-page":"e24811","DOI":"10.1002\/jcla.24811","volume":"37","author":"Y Huang","year":"2023","unstructured":"Huang Y, Huang Z, Cai H, Zhuge L, Wang S, Yan D, Zhang X, An C, Niu L, Li Z. Evaluation of serum B7-H3 expression, ultrasound and clinical characteristics to predict the risk of cervical lymph node metastases in papillary thyroid carcinoma by nomogram. J Clin Lab Anal. 2023;37(1):e24811.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"1867_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1089\/thy.2014.0294","volume":"25","author":"SC Londero","year":"2015","unstructured":"Londero SC, Krogdahl A, Bastholt L, Overgaard J, Pedersen HB, Hahn CH, Bentzen J, Schytte S, Christiansen P, Gerke O, et al. Papillary thyroid carcinoma in Denmark, 1996\u20132008: outcome and evaluation of established prognostic scoring systems in a prospective national cohort. Thyroid. 2015;25(1):78\u201384.","journal-title":"Thyroid"},{"issue":"5","key":"1867_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1055\/a-2057-8358","volume":"55","author":"J Gong","year":"2023","unstructured":"Gong J, Zhu B, Liu W, Shi C, Xia C, Zeng L, Lv Y. Risk factors for Lymph Node Metastasis in Papillary thyroid carcinoma: a retrospective study. Horm Metab Res. 2023;55(5):315\u201322.","journal-title":"Horm Metab Res"},{"issue":"11","key":"1867_CR35","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1002\/hed.25941","volume":"41","author":"SY Xu","year":"2019","unstructured":"Xu SY, Yao JJ, Zhou W, Chen L, Zhan WW. Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion. Head Neck. 2019;41(11):3984\u201391.","journal-title":"Head Neck"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-01867-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01867-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T10:13:58Z","timestamp":1739441638000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-01867-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1867"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-01867-7","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The public datasets analyzed in this study were publicly available and therefore did not require ethics approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"39"}}